ReviewNephrology (Carlton, Vic.)2025
Identifying and Characterising a Chronic Kidney Disease Electronic-Phenotype Using Electronic Health Record-Derived Data: A Narrative Review of Strategies and Applications.
Review in Nephrology (Carlton, Vic.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Evaluation of a Chronic Kidney Disease e-Phenotype: Identification and Characterisation by Electronic Health Record Data.Nephrology (Carlton, Vic.) · 2026Article
- Deficit accumulation frailty and risk of incident chronic kidney disease: a prospective analysis of the UK biobank and CHARLS cohorts.International urology and nephrology · 2026Article
- Identifying and Characterising a Chronic Kidney Disease Electronic-Phenotype Using Electronic Health Record-Derived Data: A Narrative Review of Strategies and Applications.Nephrology (Carlton, Vic.) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic kidney disease (CKD) represents a significant and growing healthcare burden. As CKD is defined and staged using laboratory values, it can be readily identified and characterised via data points derived from the electronic health record (EHR). This narrative literature review describes various strategies that have been employed to develop such a CKD 'e-phenotype,' evaluating accuracy, fidelity, and practicality. Methods discussed include the use of International Classification of Diseases (ICD) codes, estimated glomerular filtration rate (eGFR) and proteinuria criteria, free-text analysis and natural language processing (NLP), and machine learning techniques. Considerable variability in algorithm performance and complexity exists, with the use of eGFR and proteinuria criteria likely constituting the most practical and reliable basis for a CKD e-phenotype. In addition, promising current and future applications of the CKD e-phenotype have been outlined, such as characterising the burden of CKD complications and comorbid disease, and use as a tool to encourage optimisation of CKD management with quality, guideline-directed care. Future directions and challenges may involve integration of risk stratification and clinical decision support systems, alongside applications across public health resourcing and clinical trial recruitment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.